ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,332.87
0.09%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Tenax Therapeutics Inc (TENX) Share Price

TENX Tenax Therapeutics Inc

3.50
-0.06 (-1.69%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Tenax Therapeutics Inc NASDAQ:TENX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.06 -1.69 3.50 3.29 9.00 3.6293 3.50 3.56 15,990 04:00:02   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -7.71M -25.8515 -0.14 1.05M
 Type  Size  Price  Time  Units 
 9 5 3.50 21:57:53 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore TENX News
24/05/202421:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
21/05/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
21/05/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
14/05/202421:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/05/202414:01EDGAR2Form 8-K - Current report
14/05/202413:00GLOBETenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
30/04/202412:30GLOBETenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Period
Draw mode
Data Downloads for TENX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Tenax Therapeutics Inc Articles